Medinotec Inc.
MDNC
$5.00
$0.000.00%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 70.46% | 56.62% | 28.09% | 414.25% | 200.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 70.46% | 56.62% | 28.09% | 414.25% | 200.79% |
| Cost of Revenue | 85.50% | -11.02% | 33.87% | 1,491.15% | 561.52% |
| Gross Profit | 54.14% | 145.76% | 20.48% | 187.58% | 88.95% |
| SG&A Expenses | 98.32% | -41.47% | -28.21% | 79.36% | 13.73% |
| Depreciation & Amortization | -58.10% | -37.45% | 65.52% | 57.26% | 44.35% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 88.93% | -21.89% | 16.79% | 363.67% | 161.77% |
| Operating Income | 3.08% | 696.06% | 104.54% | 682.23% | 558.19% |
| Income Before Tax | 22.75% | 928.61% | 212.16% | 1,377.60% | 954.68% |
| Income Tax Expenses | 17.42% | 404.86% | 171.75% | 8,492.86% | 6,445.00% |
| Earnings from Continuing Operations | 30.50% | 1,398.17% | 163.02% | 957.53% | 291.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.50% | 1,398.17% | 163.02% | 957.53% | 291.03% |
| EBIT | 3.08% | 696.06% | 104.54% | 682.23% | 558.19% |
| EBITDA | -2.53% | 600.82% | 100.62% | 520.59% | 391.43% |
| EPS Basic | 31.08% | 976.64% | 175.00% | 814.29% | 289.47% |
| Normalized Basic EPS | 15.70% | 575.00% | 193.14% | 1,182.35% | 1,000.00% |
| EPS Diluted | 31.08% | 976.64% | 175.00% | 814.29% | 289.47% |
| Normalized Diluted EPS | 15.70% | 575.00% | 193.14% | 1,182.35% | 1,000.00% |
| Average Basic Shares Outstanding | 0.00% | 39.50% | -15.97% | 21.34% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 39.50% | -15.97% | 21.34% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |